These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16440513)

  • 1. Retrospective evaluation of tiagabine overdose.
    Spiller HA; Winter ML; Ryan M; Krenzelok EP; Anderson DL; Thompson M; Kumar S
    Clin Toxicol (Phila); 2005; 43(7):855-9. PubMed ID: 16440513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tiagabine overdose--report of two cases].
    Wiśniewski M; Sein Anand J; Chodorowski Z; Kosińska-Tomczyk H
    Przegl Lek; 2007; 64(4-5):308-9. PubMed ID: 17724893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiagabine overdose: a case of status epilepticus in a non-epileptic patient.
    Fulton JA; Hoffman RS; Nelson LS
    Clin Toxicol (Phila); 2005; 43(7):869-71. PubMed ID: 16440516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of toxicity and trends in the use of tiagabine as reported to US poison centers from 2000 to 2012.
    Spiller HA; Wiles D; Russell JL; Casavant MJ
    Hum Exp Toxicol; 2016 Feb; 35(2):109-13. PubMed ID: 25825412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizures in a pediatric patient with a tiagabine overdose.
    Kazzi ZN; Jones CC; Morgan BW
    J Med Toxicol; 2006 Dec; 2(4):160-2. PubMed ID: 18072137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deliberate overdose with the novel anticonvulsant tiagabine.
    Leach JP; Stolarek I; Brodie MJ
    Seizure; 1995 Jun; 4(2):155-7. PubMed ID: 7670769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes in newer anticonvulsant overdose: a poison center observational study.
    Wills B; Reynolds P; Chu E; Murphy C; Cumpston K; Stromberg P; Rose R
    J Med Toxicol; 2014 Sep; 10(3):254-60. PubMed ID: 24515527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intentional overdose with tiagabine: an unusual clinical presentation.
    Cantrell FL; Ritter M; Himes E
    J Emerg Med; 2004 Oct; 27(3):271-2. PubMed ID: 15388215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphenhydramine and dimenhydrinate poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Scharman EJ; Erdman AR; Wax PM; Chyka PA; Caravati EM; Nelson LS; Manoguerra AS; Christianson G; Olson KR; Woolf AD; Keyes DC; Booze LL; Troutman WG
    Clin Toxicol (Phila); 2006; 44(3):205-23. PubMed ID: 16749537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective review of Tizanidine (Zanaflex) overdose.
    Spiller HA; Bosse GM; Adamson LA
    J Toxicol Clin Toxicol; 2004; 42(5):593-6. PubMed ID: 15462150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lamotrigine overdose: a systematic review of published adult and pediatric cases.
    Alyahya B; Friesen M; Nauche B; Laliberté M
    Clin Toxicol (Phila); 2018 Feb; 56(2):81-89. PubMed ID: 28862044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirteen years of oxcarbazepine exposures reported to US poison centers: 2000 to 2012.
    Spiller HA; Strauch J; Essing-Spiller SJ; Burns G
    Hum Exp Toxicol; 2016 Oct; 35(10):1055-9. PubMed ID: 26612556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multicenter evaluation of tramadol exposure.
    Spiller HA; Gorman SE; Villalobos D; Benson BE; Ruskosky DR; Stancavage MM; Anderson DL
    J Toxicol Clin Toxicol; 1997; 35(4):361-4. PubMed ID: 9204095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deliberate self-poisoning with tiagabine: an unusual toxidrome.
    Forbes RA; Kalra H; Hackett LP; Daly FF
    Emerg Med Australas; 2007 Dec; 19(6):556-8. PubMed ID: 18021110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of lamotrigine toxicity reported to poison centers.
    Lofton AL; Klein-Schwartz W
    Ann Pharmacother; 2004 Nov; 38(11):1811-5. PubMed ID: 15353576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiagabine overdose can induce convulsive status epilepticus.
    Ostrovskiy D; Spanaki MV; Morris GL
    Epilepsia; 2002 Jul; 43(7):773-4. PubMed ID: 12102683
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the effectiveness of add-on therapy with tiagabine and evaluation of cognitive functions after application of this therapy in patients with drug-resistant focal epilepsy - an observational study (GABI-EPI)].
    Halczuk I; Lipa A; Mitosek-Szewczyk K; Sobolewski P; Stelmasiak Z; Kaczyński K
    Wiad Lek; 2015; 68(4 Pt 2):680-9. PubMed ID: 27162312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and onset of delayed seizures after overdoses of extended-release bupropion.
    Starr P; Klein-Schwartz W; Spiller H; Kern P; Ekleberry SE; Kunkel S
    Am J Emerg Med; 2009 Oct; 27(8):911-5. PubMed ID: 19857406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
    Kälviäinen R; Brodie MJ; Duncan J; Chadwick D; Edwards D; Lyby K
    Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontal nonconvulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria.
    Piccinelli P; Borgatti R; Perucca E; Tofani A; Donati G; Balottin U
    Epilepsia; 2000 Nov; 41(11):1485-8. PubMed ID: 11077464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.